Correlation Between Blueprint Medicines and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on Blueprint Medicines and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and Anebulo Pharmaceuticals.
Diversification Opportunities for Blueprint Medicines and Anebulo Pharmaceuticals
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Blueprint and Anebulo is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between Blueprint Medicines and Anebulo Pharmaceuticals
Given the investment horizon of 90 days Blueprint Medicines Corp is expected to generate 0.89 times more return on investment than Anebulo Pharmaceuticals. However, Blueprint Medicines Corp is 1.12 times less risky than Anebulo Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.17 per unit of risk. If you would invest 8,682 in Blueprint Medicines Corp on November 30, 2024 and sell it today you would earn a total of 975.00 from holding Blueprint Medicines Corp or generate 11.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Blueprint Medicines Corp vs. Anebulo Pharmaceuticals
Performance |
| Timeline |
| Blueprint Medicines Corp |
| Anebulo Pharmaceuticals |
Blueprint Medicines and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Blueprint Medicines and Anebulo Pharmaceuticals
The main advantage of trading using opposite Blueprint Medicines and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |